News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
31,082 Results
Type
Article (1752)
Press Release (29330)
Section
Business (9192)
Career Advice (7)
Deals (2346)
Drug Development (3086)
Employer Resources (2)
FDA (819)
Job Trends (577)
News (16042)
Policy (1519)
Tag
Academia (19)
Allergies (1)
Alliances (2315)
Alzheimer's disease (16)
Approvals (828)
Artificial intelligence (3)
Autoimmune disease (1)
Bankruptcy (14)
Best Places to Work (309)
Brain cancer (1)
Breast cancer (4)
Cancer (43)
Cardiovascular disease (4)
Career advice (6)
CAR-T (4)
Cell therapy (16)
Clinical research (2721)
Collaboration (21)
Compensation (13)
COVID-19 (31)
C-suite (17)
Cystic fibrosis (1)
Data (71)
Depression (3)
Diabetes (10)
Diagnostics (141)
Digital health (2)
Diversity, equity & inclusion (1)
Earnings (3602)
Employer resources (2)
Events (3300)
Executive appointments (41)
FDA (855)
Funding (15)
Gene therapy (3)
GLP-1 (12)
Government (52)
Guidances (2)
Healthcare (435)
Indications (1)
Infectious disease (36)
Inflammatory bowel disease (1)
Intellectual property (1)
IPO (728)
Job creations (282)
Job search strategy (6)
Layoffs (6)
Legal (534)
Liver cancer (2)
Lung cancer (4)
Management (1)
Manufacturing (7)
Medical device (393)
Medtech (393)
Mergers & acquisitions (1634)
Metabolic disorders (15)
Neuropsychiatric disorders (1)
Neuroscience (28)
NextGen: Class of 2025 (86)
Non-profit (22)
Now hiring (1)
Obesity (5)
Opinion (2)
Ovarian cancer (3)
Parkinson's disease (2)
Partnered (1)
Patents (3)
Patient recruitment (3)
Peanut (1)
People (3163)
Phase I (630)
Phase II (992)
Phase III (1136)
Pipeline (42)
Postmarket research (249)
Preclinical (191)
Press Release (1)
Prostate cancer (2)
Radiopharmaceuticals (12)
Rare diseases (1)
Real estate (173)
Regulatory (979)
Reports (6)
Research institute (34)
RSV (4)
Schizophrenia (3)
Series A (4)
Series B (3)
Spinal muscular atrophy (1)
Startups (130)
Vaccines (10)
Date
Today (7)
Last 7 days (27)
Last 30 days (67)
Last 365 days (1006)
2025 (304)
2024 (1123)
2023 (1421)
2022 (3590)
2021 (3259)
2020 (2701)
2019 (1638)
2018 (1212)
2017 (1693)
2016 (1631)
2015 (2323)
2014 (1558)
2013 (1066)
2012 (1015)
2011 (957)
2010 (935)
Location
Africa (16)
Alabama (1)
Arizona (1)
Arkansas (1)
Asia (910)
Australia (125)
California (81)
Canada (24)
China (3)
Colorado (2)
Connecticut (2)
Delaware (5)
Europe (16725)
Florida (9)
Georgia (1)
Illinois (10)
India (3)
Indiana (5)
Iowa (1)
Japan (4)
Kansas (1)
Maryland (25)
Massachusetts (134)
Minnesota (2)
Missouri (1)
Nebraska (1)
Nevada (1)
New Jersey (34)
New York (28)
North Carolina (50)
Northern California (34)
Ohio (3)
Oregon (1)
Pennsylvania (60)
South America (27)
Southern California (42)
Texas (4)
United States (468)
Utah (2)
Virginia (14)
Washington State (12)
31,082 Results for "livanova plc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
LivaNova to Present at the Goldman Sachs Healthcare Conference
LivaNova PLC today announced Vladimir Makatsaria, Chief Executive Officer, will present in a fireside chat at the Goldman Sachs Healthcare Conference in Miami, Florida.
May 23, 2024
·
2 min read
Business
LivaNova to Announce Second-Quarter 2024 Results
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its second-quarter 2024 results on Wednesday, July 31, 2024 at 1 p.m. London time (8 a.m. Eastern Time).
June 18, 2024
·
2 min read
Business
LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer
LivaNova PLC, a market-leading medical technology company, announced Ahmet Tezel, Ph.D., will join the Company as Chief Innovation Officer, effective May 13, 2024.
April 30, 2024
·
3 min read
Business
LivaNova Reports First-Quarter 2024 Results
LivaNova PLC, a market-leading medical technology company, reported results for the quarter ended March 31, 2024 and raised full-year 2024 revenue and adjusted diluted earnings per share guidance.
May 1, 2024
·
27 min read
Press Releases
LivaNova Appoints Natalia Kozmina as Chief Human Resources Officer
January 7, 2025
·
3 min read
LivaNova Provides Update on RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression in Unipolar Patients
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced the preliminary results for the unipolar patient cohort of the RECOVER clinical study, assessing the use of VNS Therapy™ in treatment-resistant depression.
June 6, 2024
·
5 min read
Business
LivaNova to Announce First-Quarter 2024 Results
LivaNova PLC, a market-leading medical technology company, will host a conference call to discuss its first-quarter 2024 results on Wednesday, May 1, 2024 at 1 p.m. London time.
March 21, 2024
·
2 min read
LivaNova to Present at the Barclays Global Healthcare Conference
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced Vladimir Makatsaria, Chief Executive Officer, will present in a fireside chat at the Barclays Global Healthcare Conference in Miami, Florida.
March 4, 2024
·
2 min read
Press Releases
RECOVER Clinical Study Shows Meaningful Benefits of LivaNova’s VNS Therapy System in Select Secondary Endpoints for Unipolar Patients with Treatment-Resistant Depression
December 18, 2024
·
10 min read
Business
LivaNova Reports Fourth-Quarter and Full-Year 2023 Results
LivaNova PLC, a market-leading medical technology company, reported results for the quarter and full year ended December 31, 2023 and issued guidance for 2024.
February 21, 2024
·
36 min read
1 of 3,109
Next
